Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur J Matas

Showing results (31-40 of 233) with videos related to

Pageof 24
Sort By:
Clinical Transplantation|February 25, 2017
Living donor kidney allograft survival ≥ 50 yearsOscar K Serrano, Arthur J Matas
JAMA Surgery|August 7, 2020
Organ Donation After EuthanasiaArthur J Matas, William D Payne
Transplant International : Official Journal of the European Society for Organ Transplantation|September 27, 2019
Rapid discontinuation of prednisone in kidney transplant recipients from at-risk subgroups: an OPTN/SRTR analysisDavid M Vock, Arthur J Matas
Nature Reviews. Nephrology|February 13, 2021
Risk of kidney disease after living kidney donationArthur J Matas, Andrew D Rule
Transplantation|March 17, 2004
Medication noncompliance: another iceberg's tipThomas E Nevins, Arthur J Matas
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|February 27, 2019
Retransplant Outcomes Compared With First Kidney Transplants: Important Observations Not Reported in the Scientific Registry of Transplant Recipients Annual ReportOscar K Serrano, Arthur J Matas
Nature Reviews. Urology|July 27, 2016
Transplantation: Increasing the use of available deceased donor kidneysArthur J Matas, William D Payne
Advances in Chronic Kidney Disease|June 27, 2012
Living donation: the global perspectiveArthur J Matas, Francis L Delmonico
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 11, 2020
The family voucher program: A 50-year simulationArthur J Matas, Erika S Helgeson
Kidney International|October 1, 2014
The high cost of organ transplant commercialismArthur J Matas, Robert S Gaston
Pageof 24

Showing results (31-40 of 233) with videos related to

Sort By:
Pageof 24
Clinical Transplantation|February 25, 2017
Living donor kidney allograft survival ≥ 50 yearsOscar K Serrano, Arthur J Matas
JAMA Surgery|August 7, 2020
Organ Donation After EuthanasiaArthur J Matas, William D Payne
Transplant International : Official Journal of the European Society for Organ Transplantation|September 27, 2019
Rapid discontinuation of prednisone in kidney transplant recipients from at-risk subgroups: an OPTN/SRTR analysisDavid M Vock, Arthur J Matas
Nature Reviews. Nephrology|February 13, 2021
Risk of kidney disease after living kidney donationArthur J Matas, Andrew D Rule
Transplantation|March 17, 2004
Medication noncompliance: another iceberg's tipThomas E Nevins, Arthur J Matas
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|February 27, 2019
Retransplant Outcomes Compared With First Kidney Transplants: Important Observations Not Reported in the Scientific Registry of Transplant Recipients Annual ReportOscar K Serrano, Arthur J Matas
Nature Reviews. Urology|July 27, 2016
Transplantation: Increasing the use of available deceased donor kidneysArthur J Matas, William D Payne
Advances in Chronic Kidney Disease|June 27, 2012
Living donation: the global perspectiveArthur J Matas, Francis L Delmonico
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 11, 2020
The family voucher program: A 50-year simulationArthur J Matas, Erika S Helgeson
Kidney International|October 1, 2014
The high cost of organ transplant commercialismArthur J Matas, Robert S Gaston
Pageof 24